Thus, despite clearer understanding of the physiological function of Ro52/TRIM21 in vitro, it is still unclear how anti-Ro52/TRIM21 antibodies arise, particularly in vivo, and whether they have any pathologic significance in SSc or other systemic autoimmune rheumatic diseases. The gene discussed is TRIM21; the disease is systemic sclerosis.